Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15007122Phase 4Recruiting
Phase 4, randomised, open-label trial of tranexamic acid in intertrochanteric fracture (2 arms), sponsored by Southern Medical University. Primary endpoints: Total perioperative blood loss, Postoperative transfusion rate and 1 more. Started Oct 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15007122.